Seres Therapeutics, Inc.MCRBNASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P0
Near historical low
vs 5Y Ago
-25.7x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -770.56% |
| Q3 2025 | 116.32% |
| Q2 2025 | -150.12% |
| Q1 2025 | 168.96% |
| Q4 2024 | -11.96% |
| Q3 2024 | 12.78% |
| Q2 2024 | -13.07% |
| Q1 2024 | 27.03% |
| Q4 2023 | 20.76% |
| Q3 2023 | -194.29% |
| Q2 2023 | 180.28% |
| Q1 2023 | -43.12% |
| Q4 2022 | 7.36% |
| Q3 2022 | -16.84% |
| Q2 2022 | 24.98% |
| Q1 2022 | -29.85% |
| Q4 2021 | -143.22% |
| Q3 2021 | 392.67% |
| Q2 2021 | -37.00% |
| Q1 2021 | -69.88% |
| Q4 2020 | 30.00% |
| Q3 2020 | -0.54% |
| Q2 2020 | -6.05% |
| Q1 2020 | -65.43% |
| Q4 2019 | 20.17% |
| Q3 2019 | -51.84% |
| Q2 2019 | 62.91% |
| Q1 2019 | -354.23% |
| Q4 2018 | 154.59% |
| Q3 2018 | 10.67% |
| Q2 2018 | 4.83% |
| Q1 2018 | -30.16% |
| Q4 2017 | -422.66% |
| Q3 2017 | 84.88% |
| Q2 2017 | 3.44% |
| Q1 2017 | -5.30% |
| Q4 2016 | -53.79% |
| Q3 2016 | 45.95% |
| Q2 2016 | -132.51% |
| Q1 2016 | 865.44% |